These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Liquid biopsies to optimize therapeutic efficacy in unresponsive lung cancer patients. Santarpia M; Funel N; Ali A; Giovannetti E Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):761-763. PubMed ID: 29933706 [No Abstract] [Full Text] [Related]
4. [Application of Liquid Biopsy for Lung Cancer Treatment.]. Mori S; Yatabe Y Rinsho Byori; 2016 May; 64(4):407-411. PubMed ID: 29182807 [TBL] [Abstract][Full Text] [Related]
5. Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy. Chen K; Sun J; Zhao H; Jiang R; Zheng J; Li Z; Peng J; Shen H; Zhang K; Zhao J; Zhu S; Wang Y; Yang F; Wang J Mol Cancer; 2021 Jan; 20(1):23. PubMed ID: 33514352 [No Abstract] [Full Text] [Related]
6. Role of artificial intelligence in the care of patients with nonsmall cell lung cancer. Rabbani M; Kanevsky J; Kafi K; Chandelier F; Giles FJ Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29405289 [TBL] [Abstract][Full Text] [Related]
7. A Case-control Study Supporting the Use of Liquid Biopsy in the Targeted Therapy for Lung Cancer. Dai LJ; Wang C; Ding ZY Asian Pac J Cancer Prev; 2018 Jul; 19(7):1761-1766. PubMed ID: 30049184 [TBL] [Abstract][Full Text] [Related]
8. Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer. Lin CC; Huang WL; Wei F; Su WC; Wong DT Expert Rev Mol Diagn; 2015; 15(11):1427-40. PubMed ID: 26420338 [TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141 [TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of Radiomics in COPD and Lung Cancer. Refaee T; Wu G; Ibrahim A; Halilaj I; Leijenaar RTH; Rogers W; Gietema HA; Hendriks LEL; Lambin P; Woodruff HC Respiration; 2020; 99(2):99-107. PubMed ID: 31991420 [TBL] [Abstract][Full Text] [Related]
11. Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable. Kim ES; Roy UB; Ersek JL; King J; Smith RA; Martin N; Martins R; Moore A; Silvestri GA; Jett J J Thorac Oncol; 2019 Mar; 14(3):338-342. PubMed ID: 30709747 [No Abstract] [Full Text] [Related]
12. A liquid biopsy in primary lung cancer. Yoneda K; Imanishi N; Ichiki Y; Tanaka F Surg Today; 2019 Jan; 49(1):1-14. PubMed ID: 29644440 [TBL] [Abstract][Full Text] [Related]
13. Mesothelioma: an inviting but challenging target for gene therapy. Crystal RG Am J Respir Cell Mol Biol; 2010 Apr; 42(4):383-4. PubMed ID: 20228386 [No Abstract] [Full Text] [Related]
18. Impact of molecular pathology on the clinical management of lung cancer. Brambilla E; Brambilla C; Lantuejoul S Respiration; 2005; 72(3):229-32. PubMed ID: 15942289 [No Abstract] [Full Text] [Related]
19. Future Perspectives in Detecting Ferreira D; Miranda J; Martins-Lopes P; Adega F; Chaves R Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33916986 [TBL] [Abstract][Full Text] [Related]
20. [Clinical Application of Artificial Intelligence Recognition Technology in the Diagnosis of Stage T1 Lung Cancer]. Liu X; Zhou H; Hu Z; Jin Q; Wang J; Ye B Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):319-323. PubMed ID: 31109442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]